Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hugh Pemberton

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of Alzheimer'S Disease : JAD|April 23, 2016
Diagnostic Distortions: A Case Report of Progressive Apraxia of SpeechAmy Brodtmann, Hugh Pemberton, David Darby, et al.
BMC Medical Imaging|March 25, 2025
Structured reporting of gliomas based on VASARI criteria to improve report content and consistencyOlivia Goodkin, Jiaming Wu, Hugh Pemberton, et al.
Neurology|July 23, 2017
Motor speech signature of behavioral variant frontotemporal dementia: Refining the phenotypeAdam P Vogel, Matthew L Poole, Hugh Pemberton, et al.
Psychiatry Research. Neuroimaging|March 11, 2019
An examination of orbitofrontal sulcogyral morphology in obsessive-compulsive disorderRebekah Delahoy, Cali F Bartholomeusz, Hugh Pemberton, et al.
The British Journal of Radiology|August 2, 2019
The quantitative neuroradiology initiative framework: application to dementiaOlivia Goodkin, Hugh Pemberton, Sjoerd B Vos, et al.
Neurology|November 10, 2022
Predicting Cognitive Decline in Older Adults Using Baseline Metrics of AD Pathologies, Cerebrovascular Disease, and NeurodegenerationLloyd Prosser, Amy Macdougall, Carole H Sudre, et al.
Neuroinformatics|February 17, 2020
Automated White Matter Hyperintensity Segmentation Using Bayesian Model Selection: Assessment and Correlations with Cognitive ChangeCassidy M Fiford, Carole H Sudre, Hugh Pemberton, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 17, 2024
Biomarker pathway heterogeneity of amyloid-positive individualsLloyd Prosser, Carole H Sudre, Neil P Oxtoby, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 4, 2024
Stress testing the Centiloid: Precision and variability of PET quantification of amyloid pathologyMahnaz Shekari, David Vállez García, Lyduine E Collij, et al.
Neurology|October 27, 2017
Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegenerationPhilip S J Weston, Teresa Poole, Natalie S Ryan, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of Alzheimer'S Disease : JAD|April 23, 2016
Diagnostic Distortions: A Case Report of Progressive Apraxia of SpeechAmy Brodtmann, Hugh Pemberton, David Darby, et al.
BMC Medical Imaging|March 25, 2025
Structured reporting of gliomas based on VASARI criteria to improve report content and consistencyOlivia Goodkin, Jiaming Wu, Hugh Pemberton, et al.
Neurology|July 23, 2017
Motor speech signature of behavioral variant frontotemporal dementia: Refining the phenotypeAdam P Vogel, Matthew L Poole, Hugh Pemberton, et al.
Psychiatry Research. Neuroimaging|March 11, 2019
An examination of orbitofrontal sulcogyral morphology in obsessive-compulsive disorderRebekah Delahoy, Cali F Bartholomeusz, Hugh Pemberton, et al.
The British Journal of Radiology|August 2, 2019
The quantitative neuroradiology initiative framework: application to dementiaOlivia Goodkin, Hugh Pemberton, Sjoerd B Vos, et al.
Neurology|November 10, 2022
Predicting Cognitive Decline in Older Adults Using Baseline Metrics of AD Pathologies, Cerebrovascular Disease, and NeurodegenerationLloyd Prosser, Amy Macdougall, Carole H Sudre, et al.
Neuroinformatics|February 17, 2020
Automated White Matter Hyperintensity Segmentation Using Bayesian Model Selection: Assessment and Correlations with Cognitive ChangeCassidy M Fiford, Carole H Sudre, Hugh Pemberton, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 17, 2024
Biomarker pathway heterogeneity of amyloid-positive individualsLloyd Prosser, Carole H Sudre, Neil P Oxtoby, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 4, 2024
Stress testing the Centiloid: Precision and variability of PET quantification of amyloid pathologyMahnaz Shekari, David Vállez García, Lyduine E Collij, et al.
Neurology|October 27, 2017
Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegenerationPhilip S J Weston, Teresa Poole, Natalie S Ryan, et al.
Pageof 2